Treatment of melasma with Pycnogenol®
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Melasma (or chloasma) is a common disorder of cutaneous hyperpigmentation predominantly affecting sun‐exposed areas in women. The pathogenesis of melasma is not fully understood and treatments are frequently disappointing and often associated with side effects. Pycnogenol® is a standardized extract of the bark of the French maritime pine (Pinus pinaster), a well‐known, potent antioxidant. Studies in vitro show that Pycnogenol® is several times more powerful than vitamin E and vitamin C. In addition, it recycles vitamin C, regenerates vitamin E and increases the endogenous antioxidant enzyme system. Pycnogenol® protects against ultraviolet (UV) radiation. Therefore its efficacy in the treatment of melasma was investigated. Thirty women with melasma completed a 30‐day clinical trial in which they took one 25 mg tablet of Pycnogenol® with meals three times daily, i.e. 75 mg Pycnogenol® per day. These patients were evaluated clinically by parameters such as the melasma area index, pigmentary intensity index and by routine blood and urine tests. After a 30‐day treatment, the average melasma area of the patients decreased by 25.86 ± 20.39 mm 2 (p < 0.001) and the average pigmentary intensity decreased by 0.47 ± 0.51 unit (p < 0.001). The general effective rate was 80%. No side effect was observed. The results of the blood and urine test parameters at baseline and at day 30 were within the normal range. Moreover, several other associated symptoms such as fatigue, constipation, pains in the body and anxiety were also improved. To conclude, Pycnogenol® was shown to be therapeutically effective and safe in patients suffering from melasma. Copyright © 2002 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Packer, L., Rimbach, G., & Virgili, F. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00090-8 · Cited by 660
Cited by
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
Williamson, G., & Manach, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.243s · Cited by 1,340
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
Solano, F., Briganti, S., Picardo, M., & Ghanem, G. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00334.x · Cited by 696
The treatment of melasma: A review of clinical trials
Gupta, A. K., Gover, M. D., Nouri, K., & Taylor, S. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.02.009 · Cited by 470
Nestor, M. S., Ablon, G., Gade, A., Han, H., & Fischer, D. L. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14537 · Cited by 410
Keen, M., & Hassan, I. (2016) · Indian Dermatology Online Journal · doi:10.4103/2229-5178.185494 · Cited by 227
Carotenoids and polyphenols in nutricosmetics, nutraceuticals, and cosmeceuticals
Anunciato, T. P., & da Rocha Filho, P. A. (2012) · Journal of Cosmetic Dermatology · doi:10.1111/j.1473-2165.2011.00600.x · Cited by 219
Nutraceuticals for Skin Care: A Comprehensive Review of Human Clinical Studies
Pérez-Sánchez, A., Barrajón-Catalán, E., Herranz-López, M., & Micol, V. (2018) · Nutrients · doi:10.3390/nu10040403 · Cited by 181
“The study conclude that Pycnogenol® is therapeutically effective and safe in patients with melasma [90].”
BackgroundSawant, O., & Khan, T. (2020) · Dermatologic Therapy · doi:10.1111/dth.13717 · Cited by 42
Photoprotection in skin of color
Seck, S., Hamad, J., Schalka, S., & Lim, H. W. (2022) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-022-00314-z · Cited by 20
Tuong, W., Walker, L., & Sivamani, R. K. (2015) · Journal of Dermatological Treatment · doi:10.3109/09546634.2014.991675 · Cited by 17
“Three studies did not have a comparison group (12,21,22).”
Background
Metadata
- Authors
- Ni, Z., Mu, Y., & Gulati, O.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2002-09
- Volume
- 16
- Issue
- 6
- Pages
- 567-571
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W2078100265
- Cited by
- 131
- References
- 1
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.